August 16, 2022

BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 11, 2022

BioLineRx to Report Second Quarter 2022 Results on August 16, 2022

June 28, 2022

BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC)